Controllable Learning (CL) is emerging as a crucial component of trustworthy machine learning. It emphasizes ensuring that learning models meet predefined targets and adapt to changing requirements without retraining. Let’s delve into the methods and applications of CL, particularly focusing on its implementation within Information Retrieval (IR) systems presented by researchers from Renmin University of… →
Adversarial attacks are attempts to trick a machine learning model into making a wrong prediction. They work by creating slightly modified versions of real-world data (like images) that a human wouldn’t notice as different but that cause the model to misclassify them. Neural networks are known to be vulnerable to adversarial attacks, raising concerns about… →
Microsoft has unveiled an extensive AI learning journey designed to deal with the diverse needs of various personas within a business, ranging from business leaders to citizen developers. This initiative is structured into four stages: Understanding AI, Preparing for AI, Using AI, and Building AI Solutions. Each stage equips organizations with the necessary skills to… →
Having high-quality photographs of products is crucial in the ever-changing realm of online marketing and e-commerce. The use of artificial intelligence (AI) has the potential to alter the product photography industry completely. Users can streamline, save money, and unleash their creativity with this platform’s professional-grade product photo editing tools—all without the need for real samples.… →
The randomized, phase 2 GRIFFIN study (NCT02874742) evaluated daratumumab plus lenalidomide/bortezomib/dexamethasone (D-RVd) in transplant-eligible newly diagnosed multiple myeloma (NDMM). We present final post hoc analyses (median follow-up, 49.6 months) of clinically relevant subgroups, including patients with high-risk cytogenetic abnormalities (HRCAs) per revised definition (del[17p], t[4;14], t[14;16], t[14;20], and/or gain/amp[1q21]). Patients received 4 induction cycles (D-RVd/RVd),… →
Cardiotoxicity is a side effect of chemotherapy in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients receiving both anthracyclines and trastuzumab. We looked for a possible protective effect of rosuvastatin against chemotherapy-induced cardiotoxicity. Methods: 50 newly diagnosed HER2 positive breast cancer patients were randomly allocated into two groups: 25patients in each. Group… →
CONCLUSIONS: Paclitaxel can cause neuropathy, lasting for a long time. Our study showed duloxetine is potentially an effective medication that can prevent subjective and objective neuropathy. →